{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T20:20:14Z","timestamp":1779394814355,"version":"3.53.1"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["241339"],"award-info":[{"award-number":["241339"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.vph.2022.106954","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T13:49:21Z","timestamp":1642600161000},"page":"106954","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Diabetic neuropathy: Molecular approach a treatment opportunity"],"prefix":"10.1016","volume":"143","author":[{"given":"S.T.","family":"M\u00e9ndez-Morales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"P\u00e9rez-De Marcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Rodr\u00edguez-Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Flores-Mej\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mart\u00ednez-Venegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"S\u00e1nchez-Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Tamay-Cach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Lomeli-Gonzal\u00e9z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Emilio Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Lehman-Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.A.","family":"Mart\u00ednez-Arredondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Vazquez-D\u00e1vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.F.","family":"Torres-Roldan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Correa-Basurto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.G.","family":"Arellano-Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2022.106954_bb0005","first-page":"51","article-title":"Diabetic neuropathies","volume":"28","author":"Ahmad","year":"2015","journal-title":"J. Int. Med. Sci. Acad."},{"issue":"3","key":"10.1016\/j.vph.2022.106954_bb0010","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.angio.2016.06.005","article-title":"Actualizaci\u00f3n en el diagn\u00f3stico, tratamiento y prevenci\u00f3n de la neuropat\u00eda diab\u00e9tica perif\u00e9rica","volume":"69","author":"Velasco","year":"2017","journal-title":"Angiologia"},{"key":"10.1016\/j.vph.2022.106954_bb0015","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jcjd.2017.10.003","article-title":"Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome","volume":"42","author":"Punthakee","year":"2018","journal-title":"Can. J. Diabetes"},{"key":"10.1016\/j.vph.2022.106954_bb0020","article-title":"Projections of the prevalence of hyperglycaemia in pregnancy in 2019 and beyond: results from the international diabetes federation diabetes atlas, 9th edition","volume":"107841","author":"Yuen","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"1","key":"10.1016\/j.vph.2022.106954_bb0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1573399812666151016101622","article-title":"Chronic complications of diabetes mellitus: a mini review","volume":"13","author":"Lotfy","year":"2017","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.vph.2022.106954_bb0030","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5935\/1806-0013.20160047","article-title":"Diabetic neuropathy","volume":"17","author":"Nascimento","year":"2016","journal-title":"Rev. Dor."},{"issue":"4","key":"10.1016\/j.vph.2022.106954_bb0035","first-page":"105","article-title":"Neuropat\u00eda diab\u00e9tica: frecuencia, factores de riesgo y calidad de vida en pacientes de una cl\u00ednica de primer nivel de atenci\u00f3n","volume":"19","author":"Ram\u00edrez-L\u00f3pez","year":"2017","journal-title":"Arch. Med. Fam."},{"key":"10.1016\/j.vph.2022.106954_bb0040","first-page":"204","article-title":"Early diabetic neuropathy: a diagnostic challenge","volume":"5","author":"Duarte","year":"2017","journal-title":"EC Neurol."},{"key":"10.1016\/j.vph.2022.106954_bb0045","doi-asserted-by":"crossref","first-page":"S217","DOI":"10.1016\/j.jcjd.2017.10.028","article-title":"Neuropathy","volume":"42","author":"Bril","year":"2018","journal-title":"Can. J. Diabetes"},{"issue":"1","key":"10.1016\/j.vph.2022.106954_bb0050","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2337\/dc16-2042","article-title":"Diabetic neuropathy: a position statement by the American Diabetes Association","volume":"40","author":"Pop-Busui","year":"2017","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.vph.2022.106954_bb0055","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10787-017-0339-y","article-title":"Nrf2: a potential therapeutic target for diabetic neuropathy","volume":"25","author":"Kumar","year":"2017","journal-title":"Inflammopharmacology"},{"issue":"1","key":"10.1016\/j.vph.2022.106954_bb0060","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3329\/dmcj.v7i1.40619","article-title":"Diabetic peripheral neuropathy: epidemiology, physiopathology, diagnosis and treatment","volume":"7","author":"Akter","year":"2019","journal-title":"Delta Med. Col. J."},{"issue":"3","key":"10.1016\/j.vph.2022.106954_bb0065","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4239\/wjd.v6.i3.432","article-title":"Diabetic neuropathic pain: physiopathology and treatment","volume":"6","author":"Schreiber","year":"2015","journal-title":"World J. Diabetes"},{"issue":"1","key":"10.1016\/j.vph.2022.106954_bb0070","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1476-511X-9-117","article-title":"The activation of CD14, TLR4, and TLR2 by mmLDL induces IL-1\u03b2, IL-6, and IL-10 secretion in human monocytes and macrophages","volume":"9","author":"Ch\u00e1vez-S\u00e1nchez","year":"2010","journal-title":"Lipids Health Dis."},{"issue":"4","key":"10.1016\/j.vph.2022.106954_bb0075","doi-asserted-by":"crossref","first-page":"680","DOI":"10.2337\/dc08-2011","article-title":"Subclinical inflammation and diabetic polyneuropathy: MONICA\/KORA survey F3 (Augsburg, Germany)","volume":"32","author":"Herder","year":"2009","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.vph.2022.106954_bb0080","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/cts.12434","article-title":"TLR4 and Caveolin-1 in monocytes are associated with inflammatory conditions in diabetic neuropathy","volume":"10","author":"Zhu","year":"2017","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.vph.2022.106954_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2017.01.004","article-title":"Diabetic microangiopathy: pathogenetic insights and novel therapeutic approaches","volume":"90","author":"Madonna","year":"2017","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.vph.2022.106954_bb0090","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.vph.2018.01.009","article-title":"Diabetic macroangiopathy: pathogenetic insights and novel therapeutic approaches with focus on high glucose-mediated vascular damage","volume":"107","author":"Madonna","year":"2018","journal-title":"Vasc. Pharmacol."},{"issue":"11","key":"10.1016\/j.vph.2022.106954_bb0095","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1046\/j.1464-5491.2002.00819.x","article-title":"Symptom scoring systems to diagnose distal polyneuropathy in diabetes: the diabetic neuropathy symptom score","volume":"19","author":"Meijer","year":"2002","journal-title":"Diabet. Med."},{"issue":"36","key":"10.1016\/j.vph.2022.106954_bb0100","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.2174\/138161207783018545","article-title":"Non enzymatic glycated proteins in the blood and cardiovascular disease","volume":"13","author":"Misciagna","year":"2007","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.vph.2022.106954_bb0105","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/08830185.2013.849702","article-title":"The emerging role of the receptor for advanced glycation end products on innate immunity","volume":"33","author":"Rojas","year":"2014","journal-title":"Int. Rev. Immunol."},{"issue":"5\u20136","key":"10.1016\/j.vph.2022.106954_bb0110","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.vph.2012.06.004","article-title":"The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes","volume":"57","author":"Ramasamy","year":"2012","journal-title":"Vasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.vph.2022.106954_bb0115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1189\/jlb.1012519","article-title":"RAGE regulation and signaling in inflammation and beyond","volume":"94","author":"Kierdorf","year":"2013","journal-title":"J. Leukoc. Biol."},{"issue":"13","key":"10.1016\/j.vph.2022.106954_bb0120","doi-asserted-by":"crossref","first-page":"7947","DOI":"10.1073\/pnas.1331358100","article-title":"Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2","volume":"100","author":"Abbadie","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.vph.2022.106954_bb0125","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.neuron.2017.02.005","article-title":"New horizons in diabetic neuropathy: mechanisms, bioenergetics, and pain","volume":"93","author":"Feldman","year":"2017","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.vph.2022.106954_bb0130","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.3390\/ijms18112296","article-title":"Pharmacological regulation of neuropathic pain driven by inflammatory macrophages","volume":"18","author":"Kiguchi","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.vph.2022.106954_bb0135","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.neuron.2014.04.009","article-title":"TNF-\u03b1\/TNFR1 signaling is required for the development and function of primary nociceptors","volume":"82","author":"Wheeler","year":"2014","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.vph.2022.106954_bb0140","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0306-4522(00)00396-1","article-title":"Hyperalgesia due to nerve injury: role of neutrophils","volume":"101","author":"Perkins","year":"2000","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.vph.2022.106954_bb0145","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0306-4522(02)00065-9","article-title":"Macrophage and lymphocyte invasion of dorsal root ganglia after peripheral nerve lesions in the rat","volume":"112","author":"Hu","year":"2002","journal-title":"Neuroscience"},{"issue":"20","key":"10.1016\/j.vph.2022.106954_bb0150","doi-asserted-by":"crossref","first-page":"12603","DOI":"10.1074\/jbc.M115.636506","article-title":"Macrophage-T cell interactions mediate neuropathic pain through the glucocorticoid-induced tumor necrosis factor ligand system","volume":"290","author":"Kobayashi","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.vph.2022.106954_bb0155","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1474-4422(12)70134-5","article-title":"The role of the immune system in the generation of neuropathic pain","volume":"11","author":"Calvo","year":"2012","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.vph.2022.106954_bb0160","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1111\/dme.13083","article-title":"Systematic review of treatments for diabetic peripheral neuropathy","volume":"33","author":"\u00c7akici","year":"2016","journal-title":"Diabet. Med."},{"issue":"10","key":"10.1016\/j.vph.2022.106954_bb0165","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.3390\/nu10101423","article-title":"Effect of resveratrol, a dietary-derived polyphenol, on the oxidative stress and polyol pathway in the lens of rats with streptozotocin-induced diabetes","volume":"10","author":"Sedlak","year":"2018","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.vph.2022.106954_bb0170","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/med.21565","article-title":"Health benefits of resveratrol: evidence from clinical studies","volume":"39","author":"Singh","year":"2019","journal-title":"Med. Res. Rev."},{"issue":"3","key":"10.1016\/j.vph.2022.106954_bb0175","doi-asserted-by":"crossref","first-page":"183","DOI":"10.5551\/jat.50658","article-title":"Prevention of cardiovascular events with omega-3 polyunsaturated fatty acids and the mechanism involved","volume":"27","author":"Watanabe","year":"2020","journal-title":"J. Atheroscler. Thromb."},{"issue":"11","key":"10.1016\/j.vph.2022.106954_bb0180","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/j.bbadis.2015.08.001","article-title":"Oxidative stress, mitochondrial damage and diabetic retinopathy","volume":"1852","author":"Kowluru","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.vph.2022.106954_bb0185","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrneurol.2016.201","article-title":"Schwann cell interactions with axons and microvessels in diabetic neuropathy","volume":"13","author":"Gon\u00e7alves","year":"2017","journal-title":"Nat. Rev. Neurol."},{"issue":"6","key":"10.1016\/j.vph.2022.106954_bb0190","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/jdi.12833","article-title":"Diabetic neuropathy and the sensory neuron: new aspects of pathogenesis and their treatment implications","volume":"9","author":"Kobayashi","year":"2018","journal-title":"J. Diabetes Investig."},{"issue":"4","key":"10.1016\/j.vph.2022.106954_bb0195","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1039\/C6MB00014B","article-title":"Metabolomics in diabetic complications","volume":"12","author":"Filla","year":"2016","journal-title":"Mol. BioSyst."},{"key":"10.1016\/j.vph.2022.106954_bb0200","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1016\/j.dsx.2016.12.022","article-title":"Diabetes microvascular complications\u2014A clinical update","volume":"11","author":"Khalil","year":"2017","journal-title":"Diabetes Metab. Syndr."},{"key":"10.1016\/j.vph.2022.106954_bb0205","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ejphar.2018.06.034","article-title":"Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets","volume":"833","author":"Dewanjee","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.vph.2022.106954_bb0210","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejphar.2013.07.017","article-title":"Pathogenesis of diabetic neuropathy: focus on neurovascular mechanisms","volume":"719","author":"Van Dam","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.vph.2022.106954_bb0215","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4239\/wjd.v6.i4.554","article-title":"Toxic stress, inflammation and symptomatology of chronic complications in diabetes","volume":"6","author":"Downs","year":"2015","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.vph.2022.106954_bb0220","doi-asserted-by":"crossref","first-page":"107784","DOI":"10.1016\/j.diabres.2019.107784","article-title":"Evaluation of risk factors in the development of type 2 diabetes in a Mexican population","volume":"155","author":"Mart\u00ednez-Venegas","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.vph.2022.106954_bb0225","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.arr.2017.08.003","article-title":"Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: a systematic review and meta-analysis","volume":"40","author":"Campbell","year":"2017","journal-title":"Ageing Res. Rev."},{"issue":"4","key":"10.1016\/j.vph.2022.106954_bb0230","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.vph.2022.106954_bb0235","article-title":"The effect of \u03b1-lipoic acid treatment on plasma asymmetric dimethylarginine, a biomarker of endothelial dysfunction in diabetic neuropathy","volume":"16","author":"Sztanek","year":"2020","journal-title":"Arch. Med. Sci."},{"issue":"2","key":"10.1016\/j.vph.2022.106954_bb0240","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2337\/dbi15-0034","article-title":"Diabetic central neuropathy: CNS damage related to hyperglycemia","volume":"65","author":"Malone","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.vph.2022.106954_bb0245","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.phrs.2013.12.005","article-title":"Diabetic peripheral neuropathy: current perspective and future directions","volume":"80","author":"Singh","year":"2014","journal-title":"Pharmacol. Res."},{"issue":"17","key":"10.1016\/j.vph.2022.106954_bb0250","first-page":"958","article-title":"Complicaciones microvasculares de la diabetes","volume":"12","author":"P\u00e9rez-Pevida","year":"2016","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.vph.2022.106954_bb0255","doi-asserted-by":"crossref","first-page":"546","DOI":"10.4103\/2230-8210.183480","article-title":"Microvasular and macrovascular complications in diabetes mellitus: distinct or continuum?","volume":"20","author":"Chawla","year":"2016","journal-title":"Indian J. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.vph.2022.106954_bb0260","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s00125-014-3461-z","article-title":"The effects of capillary dysfunction on oxygen and glucose extraction in diabetic neuropathy","volume":"58","author":"\u00d8stergaard","year":"2015","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.vph.2022.106954_bb0265","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2337\/db14-0759","article-title":"Diabetic microangiopathy: impact of impaired cerebral vasoreactivity and delayed angiogenesis after permanent middle cerebral artery occlusion on stroke damage and cerebral repair in mice","volume":"64","author":"Poittevin","year":"2015","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.vph.2022.106954_bb0270","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.vph.2009.06.008","article-title":"Early inhibition of EGFR signaling prevents diabetes-induced up-regulation of multiple gene pathways in the mesenteric vasculature","volume":"51","author":"Benter","year":"2009","journal-title":"Vasc. Pharmacol."},{"issue":"8","key":"10.1016\/j.vph.2022.106954_bb0275","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1042\/CS20150124","article-title":"Vascular endothelial growth factor-A165b prevents diabetic neuropathic pain and sensory neuronal degeneration","volume":"129","author":"Hulse","year":"2015","journal-title":"Clin. Sci."},{"issue":"1","key":"10.1016\/j.vph.2022.106954_bb0280","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0003319715583595","article-title":"Small-fiber neuropathy: a diabetic microvascular complication of special clinical, diagnostic, and prognostic importance","volume":"67","author":"K\u00f6rei","year":"2016","journal-title":"Angiology"},{"key":"10.1016\/j.vph.2022.106954_bb0285","doi-asserted-by":"crossref","first-page":"106559","DOI":"10.1016\/j.vph.2019.04.001","article-title":"HMGB1 enhances AGE-mediated VSMC proliferation via an increase in 5-LO-linked RAGE expression","volume":"118","author":"Jang","year":"2019","journal-title":"Vasc. Pharmacol."},{"issue":"3","key":"10.1016\/j.vph.2022.106954_bb0290","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000438794","article-title":"Diabetic retinopathy: need for more research to understand the relative role of neuropathy and microvascular disease","volume":"54","author":"Cunha-Vaz","year":"2015","journal-title":"Ophthalmic Res."},{"issue":"14","key":"10.1016\/j.vph.2022.106954_bb0295","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003340","article-title":"Autonomic neuropathy and endothelial dysfunction in patients with impaired glucose tolerance or type 2 diabetes mellitus","volume":"95","author":"Tiftikcioglu","year":"2016","journal-title":"Medicine"},{"issue":"9","key":"10.1016\/j.vph.2022.106954_bb0300","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1210\/jc.2016-2030","article-title":"Endothelial dysfunction as a link between cardiovascular risk factors and peripheral neuropathy in diabetes","volume":"101","author":"Roustit","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.vph.2022.106954_bb0305","first-page":"317","article-title":"Endothelial dysfunction and inflammatory biomarkers as a response factor of concurrent coenzyme Q10 add-on metformin in patients with type 2 diabetes mellitus","volume":"11","author":"Al-Kuraishy","year":"2019","journal-title":"J. Lab. Phys."},{"issue":"4","key":"10.1016\/j.vph.2022.106954_bb0310","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.dsx.2014.04.006","article-title":"The effect of angiotensin-2 receptor blocker valsartan on circulating level of endothelial progenitor cells in diabetic patients with asymptomatic coronary artery disease","volume":"9","author":"Berezin","year":"2015","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"issue":"3","key":"10.1016\/j.vph.2022.106954_bb0315","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/1358863X16681486","article-title":"Impact of DPP-4 inhibition on acute and chronic endothelial function in humans with type 2 diabetes on background metformin therapy","volume":"22","author":"Widlansky","year":"2017","journal-title":"Vasc. Med."},{"key":"10.1016\/j.vph.2022.106954_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2017.05.005","article-title":"Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases","volume":"100","author":"Incalza","year":"2018","journal-title":"Vasc. Pharmacol."},{"issue":"Supplement 2","key":"10.1016\/j.vph.2022.106954_bb0325","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.2337\/diab.46.2.S38","article-title":"The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy","volume":"46","author":"Low","year":"1997","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.vph.2022.106954_bb0330","first-page":"71","article-title":"Oxidative stress and diabetic neuropathy: current status of antioxidants","volume":"2","author":"Negi","year":"2011","journal-title":"IIOABJ"},{"issue":"1","key":"10.1016\/j.vph.2022.106954_bb0335","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2337\/diabetes.52.1.165","article-title":"Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy","volume":"52","author":"Schmeichel","year":"2003","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.vph.2022.106954_bb0340","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/0976-3147.91932","article-title":"Role of nitrosative and oxidative stress in neuropathy in patients with type 2 diabetes mellitus","volume":"3","author":"Al-Nimer","year":"2012","journal-title":"J. Neurosci. Rural Pract."},{"issue":"3","key":"10.1016\/j.vph.2022.106954_bb0345","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/1570161054368634","article-title":"Role for poly (ADP-ribose) polymerase activation in diabetic nephropathy, neuropathy and retinopathy","volume":"3","author":"Obrosova","year":"2005","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.vph.2022.106954_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2008.05.005","article-title":"Diabetic neuropathy: mechanisms to management","volume":"120","author":"Edwards","year":"2008","journal-title":"Pharmacol. Ther."},{"issue":"22","key":"10.1016\/j.vph.2022.106954_bb0355","doi-asserted-by":"crossref","first-page":"12222","DOI":"10.1073\/pnas.97.22.12222","article-title":"Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation","volume":"97","author":"Du","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.vph.2022.106954_bb0360","doi-asserted-by":"crossref","first-page":"8669","DOI":"10.1007\/s11033-012-1722-9","article-title":"Evaluation of oxidative stress markers in pathogenesis of diabetic neuropathy","volume":"39","author":"Kasznicki","year":"2012","journal-title":"Mol. Biol. Rep."},{"issue":"6","key":"10.1016\/j.vph.2022.106954_bb0365","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1096\/fj.04-2513fje","article-title":"Short-term hyperglycemia produces oxidative damage and apoptosis in neurons","volume":"19","author":"Vincent","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.vph.2022.106954_bb0370","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.clinbiochem.2019.05.008","article-title":"Effects of zinc supplementation on superoxide dismutase activity and gene expression, and metabolic parameters in overweight type 2 diabetes patients: a randomized, double-blind, controlled trial","volume":"69","author":"Nazem","year":"2019","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.vph.2022.106954_bb0375","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ctim.2019.03.001","article-title":"Propolis supplementation improves glycemic and antioxidant status in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study","volume":"43","author":"Afsharpour","year":"2019","journal-title":"Complement Ther. Med."},{"issue":"24","key":"10.1016\/j.vph.2022.106954_bb0380","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1212\/WNL.0000000000004033","article-title":"Effect of omega-3 supplementation on neuropathy in type 1 diabetes: a 12-month pilot trial","volume":"88","author":"Lewis","year":"2017","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.vph.2022.106954_bb0385","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pharep.2013.08.003","article-title":"Assessment of antioxidant supplementation on the neuropathic pain score and quality of life in diabetic neuropathy patients\u2013a randomized controlled study","volume":"66","author":"Rajanandh","year":"2014","journal-title":"Pharmacol. Rep."},{"issue":"2","key":"10.1016\/j.vph.2022.106954_bb0390","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3390\/nu13020395","article-title":"Vitamin B12 supplementation in diabetic neuropathy: a 1-year, randomized, double-blind, placebo-controlled trial","volume":"13","author":"Didangelos","year":"2021","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.vph.2022.106954_bb0395","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1139\/cjpp-2019-0677","article-title":"Why the endothelium? The endothelium as a target to reduce diabetes-associated vascular disease","volume":"98","author":"Triggle","year":"2020","journal-title":"Can. J. Physiol. Pharmacol."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189122000039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189122000039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T01:20:20Z","timestamp":1761528020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189122000039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":79,"alternative-id":["S1537189122000039"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2022.106954","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetic neuropathy: Molecular approach a treatment opportunity","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2022.106954","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106954"}}